TipRanks
2 days ago
TipRanks
2 days ago
TipRanks
2 days ago
TipRanks
2 days ago
The Cerbat Gem
2 days ago
The Cerbat Gem
2 days ago
The Cerbat Gem
2 days ago
The Cerbat Gem
2 days ago
The Cerbat Gem
2 days ago
Invezz News
2 days ago
TheStreet - Investing
2 days ago
TipRanks
2 days ago
TipRanks
2 days ago
PYMNTS
2 days ago
PYMNTS
2 days ago

Pyxis Oncology Stock Soars Over 5% Overnight: Here's What You Need to Know

Benzinga
2 days ago

Bitcoin at $600,000 in 3-5 Years? Popular Analyst Says It Could Happen

Benzinga
2 days ago

ProQR Therapeutics (NASDAQ:PRQR) Shares Cross Above 50 Day Moving Average - Should You Sell?

The Cerbat Gem
2 days ago

Banks Turn Card Replacement Into a Single AI Workflow

PYMNTS
2 days ago

Anthropic Exec Admits 'We Do Not Yet Have A Plan' After Researcher Quits Over AI 'Endgame' Fears, Pegs Double-Digit Human Extinction Risk Over Next Decade

Stocktwits News Feed
2 days ago

Paycheck-to-Paycheck Consumers Have Already Cut the Lattes

PYMNTS
2 days ago

Manhattan Associates, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc.

GuruFocus
2 days ago

RXT Deadline: RXT Investors with Losses in Excess of $100K Have Opportunity to Lead Rackspace Technology, Inc. Securities Fraud Lawsuit

GuruFocus
2 days ago

62% of Businesses Make ERP Integration the Top AP Test

PYMNTS
2 days ago

CAPR Deadline: CAPR Investors with Losses in Excess of $100K Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit

GuruFocus
2 days ago

ADAMA Secures First EU Registration for Innovative Ferrabait® Molluscicide

GuruFocus
2 days ago

ASE Technology Holding Co., Ltd. Announces Monthly Net Revenues*

GuruFocus
2 days ago

Hoymiles HiOne All-in-One Home Battery Wins Four International Design Awards

PR Newswire
2 days ago

Giovanni Caforio Appointed Operating Advisor to CD&R Funds

PR Newswire
2 days ago

EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy programme for epilepsy ahead of first-in-human trial

PR Newswire
2 days ago